You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Biallelic RPE65 Mutation-associated Retinal Dystrophy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biallelic RPE65 Mutation-associated Retinal Dystrophy Trial in Beijing (FT-001 Low Dose, FT-001 Mid Dose, FT-001 High Dose)

Recruiting
  • Biallelic RPE65 Mutation-associated Retinal Dystrophy
  • FT-001 Low Dose
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 11, 2023

Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy Trial in United States (AAV2-hRPE65v2,voretigene

Active, not recruiting
  • Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy
  • AAV2-hRPE65v2,voretigene neparvovec-rzyl
  • Los Angeles, California
  • +9 more
Oct 22, 2021

Retinal Dystrophy, PRPF31 Mutationassociated Retinal Dystrophy, RP11 Trial in Dallas (VP-001)

Recruiting
  • Retinal Dystrophy
  • +2 more
  • Dallas, Texas
    Retina Foundation of the Southwest
Jun 5, 2023

Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

Recruiting
  • Retinitis Pigmentosa
  • +4 more
    • San Francisco, California
    • +4 more
    Oct 5, 2022

    Inherited Retinal Dystrophy Due to RPE65 Mutations, Leber Congenital Amaurosis Trial in Iowa City, Philadelphia

    Active, not recruiting
    Has Results
    • Inherited Retinal Dystrophy Due to RPE65 Mutations
    • Leber Congenital Amaurosis
    • AAV2-hRPE65v2,voretigene neparvovec-rzyl
    • Iowa City, Iowa
    • +1 more
    Dec 9, 2021

    Amaurosis of Leber, Retinal Diseases Trial in Gainesville, Philadelphia (rAAV2-CBSB-hRPE65)

    Active, not recruiting
    • Amaurosis of Leber
    • Retinal Diseases
    • rAAV2-CBSB-hRPE65
    • Gainesville, Florida
    • +1 more
    Dec 13, 2021

    Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)

    Active, not recruiting
    • Inherited Retinal Dystrophy Due to RPE65 Mutations
    • AAV2-hRPE65v2
    • (no location specified)
    Dec 9, 2021

    Leber Congenital Amaurosis Trial in Ann Arbor, London (AAV RPE65)

    Completed
    Has Results
    • Leber Congenital Amaurosis
    • AAV RPE65
    • Ann Arbor, Michigan
    • +1 more
    Jun 17, 2021

    Leber Congenital Amaurosis Trial in Philadelphia (voretigene neparvovec-rzyl)

    Completed
    • Leber Congenital Amaurosis
    • voretigene neparvovec-rzyl
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Oct 30, 2020

    Leber Congenital Amaurosis Associated With Mutations in RPE65

    Recruiting
    • Leber Congenital Amaurosis
      • Ann Arbor, Michigan
      • +1 more
      Apr 7, 2022

      Neurodegenerative Disease, Hereditary, Mitochondrial Diseases, Optic Atrophy Trial in Buffalo (Mutation analysis)

      Recruiting
      • Neurodegenerative Disease, Hereditary
      • +2 more
      • Mutation analysis
      • Buffalo, New York
        UBMD Pediatrics
      Mar 3, 2022

      Neurodegenerative Disease, Hereditary, Mitochondrial Diseases, Optic Atrophy Trial in Buffalo (Mutation analysis)

      Recruiting
      • Neurodegenerative Disease, Hereditary
      • +2 more
      • Mutation analysis
      • Buffalo, New York
        UBMD Pediatrics
      Mar 3, 2022

      Bietti's Crystalline Dystrophy Trial in Beijing (ZVS101e)

      Recruiting
      • Bietti's Crystalline Dystrophy
      • Beijing, Beijing, China
        Peking University Third Hospital
      Feb 2, 2023

      Cell Collection to Study Eye Diseases

      Recruiting
      • Retinal Disease
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 23, 2023

        Best Disease and Other Retinal Degenerative Diseases.

        Active, not recruiting
        • Retinal Disease
        • +4 more
          • Rochester, Minnesota
            Mayo Clinic
          Jan 4, 2022

          LCA5 Trial (AAV8.hLCA5)

          Not yet recruiting
          • LCA5
          • AAV8.hLCA5
          • (no location specified)
          Nov 22, 2022

          SMA Trial in Worldwide (Onasemnogene Abeparvovec-xioi)

          Completed
          Has Results
          • SMA
          • Onasemnogene Abeparvovec-xioi
          • Ghent, Belgium
          • +9 more
          Aug 12, 2022

          Bietti's Crystalline Dystrophy Trial in China (ZVS101e)

          Recruiting
          • Bietti's Crystalline Dystrophy
          • Beijing, Beijing, China
          • +3 more
          Apr 16, 2023

          Objective Perimetry Using Chromatic Multifocal Pupillometer

          Recruiting
          • Retinal Dystrophies
          • +2 more
            • Tel HaShomer, Israel
              Sheba Medical Center
            Jan 15, 2023

            Phenotypic Description of Atypical Clinical Forms of PLA2G6

            Enrolling by invitation
            • Neuroaxonal Dystrophy, Atypical
              • Clermont-Ferrand, France
              • +6 more
              Jun 29, 2022

              Study of BEST1 Vitelliform Macular Dystrophy

              Recruiting
              • Best Vitelliform Macular Dystrophy
              • Retinitis Pigmentosa
              • Natural History Study
              • New York, New York
              • +2 more
              Mar 30, 2023

              Retinal Imaging in Patients With Inherited Retinal Degenerations

              Recruiting
              • Retinitis Pigmentosa
                • San Francisco, California
                  Department of Ophthalmology Retinal Degenerations Clinic, UCSF
                Sep 23, 2021

                Rate of Progression in EYS Related Retinal Degeneration

                Active, not recruiting
                • Retinitis Pigmentosa
                • Eye Diseases
                  • San Francisco, California
                  • +19 more
                  Feb 3, 2022

                  To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)

                  Not yet recruiting
                  • To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)
                  • (no location specified)
                  Aug 29, 2023

                  Macular Edema, Inherited Retinal Dystrophy, Laser Retinopathy Trial in Rome (subthreshold treatment with micropulsed laser)

                  Not yet recruiting
                  • Macular Edema
                  • +2 more
                  • subthreshold treatment with micropulsed laser
                  • Rome, RM, Italy
                    IRCSS Fondazione G:B:Bietti
                  Jul 27, 2023